A live, attenuated human rotavirus vaccine appears safe and effective after 2 years of follow-up in healthy infants, according to a report in the November 15th issue of The Journal of Infectious Diseases.
An earlier tetravalent rhesus-human reassortant rotavirus vaccine was also effective, the authors explain, but it was withdrawn after being associated with the development of intussusception
תגובות רוצה להצטרף לדיון?
יש להתחבר כדי להגיב.
התחבראין תגובות עדיין. היה הראשון להגיב!